This year's nonexistent flu season could prove problematic for vaccine developers


Hospitals have seen only a few silver linings throughout the COVID-19 pandemic — a dramatic drop in the flu and other respiratory illnesses among them. But a year without the flu could actually be a problem for vaccine developers and disease forecasters, as well as for people who've gone a whole year without reinforcing their immune system against respiratory diseases, The Atlantic reports.
As 2020 ended and the pandemic began overlapping with the start of a typical flu season, the Mayo Clinic was among hospitals that began testing patients with respiratory symptoms for both COVID-19 and the flu. But among the 20,000 flu tests it conducted between December 1 and February 1, zero came back positive. The Centers for Disease Control and Prevention similarly reported a mere 0.2 percent flu positivity rate among 800,000 lab samples reported nationwide.
While the flu dropoff was great news for overwhelmed hospitals, it hasn't been helpful for scientists who monitor the flu's constant mutations. Virologists and vaccinologists typically pore through mountains of samples from around the world to predict what the next year's dominant strain will look like and make vaccines to counter it, Stacey Schultz-Cherry, a virologist and immunologist at St. Jude's Children's Hospital, tells The Atlantic. A year without exposure to the virus could also prove problematic for the human immune system, and especially for children who have been exposed to few, if any, varieties of the flu.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Scientists may not have the best view of what's going on with the flu right now. But Florian Krammer, a virologist and flu expert at the Icahn School of Medicine at Mount Sinai, suggested two possibilities. Hopefully, a lack of flu circulation "could end up throttling the circulating strains — possibly even taking one out of commission entirely," The Atlantic writes. But it's also possible the flu family tree could split in two, creating a strain scientists don't even know about until it goes viral. Read more at The Atlantic.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
July 13 editorial cartoons
Cartoons Sunday's political cartoons include new TSA rules, FEMA cuts, and Volodymyr Zelenskyy complimenting Donald Trump's new wardrobe
-
5 weather-beaten cartoons about the Texas floods
Cartoons Artists take on funding cuts, politicizing tragedy, and more
-
What has the Dalai Lama achieved?
The Explainer Tibet’s exiled spiritual leader has just turned 90, and he has been clarifying his reincarnation plans
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths